Why Young Women Have More Adverse Outcomes After a Heart Attack Than Young Men

Health & Lifestyle
278

Listen to article (english)

Translate to Spanish or other 102 languages!

Younger women who have had a heart attack have more adverse outcomes and are more likely to return to the hospital in the year following their heart attack than men of a similar age. Image for illustration purposes
Younger women who have had a heart attack have more adverse outcomes and are more likely to return to the hospital in the year following their heart attack than men of a similar age. Image for illustration purposes

Medical News Today

- Advertisement -
  • Researchers say younger women tend to have worse outcomes after having a heart attack than younger men.
  • They add that younger women are also more likely to return to the hospital in the year following a heart attack.
  • Experts say among other factors younger women tend to wait longer to seek treatment after experiencing heart ailments.

Younger women who have had a heart attack have more adverse outcomes and are more likely to return to the hospital in the year following their heart attack than men of a similar age. 

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/young-women-more-likely-to-return-to-the-hospital-in-year-following-heart-attack-emb?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-05-02&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
A Safer Blood Thinner? 
Next article
Preventing Tick Bites & Lyme Disease

More Articles

DHR Health Offers Mammogram Screening Special During “Breast Cancer Awareness Month”

October is “Breast Cancer Awareness Month,” and DHR Health is encouraging women to prioritize their breast health by offering their annual mammogram screening special.

FDA Approves First Treatment for MCT8 Deficiency

The U.S. Food and Drug Administration approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid heart rate, increased blood pressure and adverse effects on metabolism) in patients with MCT8 deficiency, also known as Allan-Herndon-Dudley syndrome.

Insomnia Linked to a Higher Risk of Stroke

 Insomnia is not only associated with poor sleep and reduced daytime functioning, but may also be an indicator of increased health risks. An international review by the European Academy of Neurology, in collaboration with MedUni Vienna, shows a link to stroke, hospital admissions and several neurological and mental health conditions. The findings were published in the high ranking journal “Sleep Medicine Reviews”.

Check Your Car Seat: Nearly 1 in 2 Are Installed Incorrectly

Mega Doctor News AUSTIN – Is your child’s car seat secure? For many...
- Advertisement -